3 completed, 2 unknown. 5 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 2 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Unknown 1 |
Follow stearic acid: new trials by email Literature Review of stearic acid trials Research Report on stearic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NBMI Treatment in Patients With Mercury Toxicity (N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate - Mercury Poisoning | Phase 2 / Phase 3 | Unknown | EmeraMed | 116 | 2023-11-22 | 2024-03-12 |
| Study Design of the Diacerein in Patients With Covid-19 Diacerein, placebo capsules - COVID-19 | Phase 2 | Unknown | University of Campinas, Brazil | 40 | 2022-04-01 | 2022-08-02 |
| Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Fucoxanthin, Placebo - Metabolic Syndrome | Phase 2 | Completed | University of Guadalajara | 28 | 2019-09-30 | 2024-11-21 |
| Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects Neurexan®, Placebo - Acute Stress Reaction | Phase 1 / Phase 2 | Completed | Biologische Heilmittel Heel GmbH | 66 | 2012-10-01 | 2015-02-11 |
| TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB Linezolid, Placebo - Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 36 | 2009-04-01 | 2026-07-06 |
Anemia (1) · COVID-19 (1) · Extensively Drug-Resistant Tuberculosis (1) · Insulin Resistance (1) · Mercury Poisoning (1) · Metabolic Syndrome (1) · Optic Nerve Diseases (1) · Peripheral Nervous System Diseases (1) · Stress Disorders, Traumatic, Acute (1) · Thrombocytopenia (1) · Tuberculosis, Multidrug-Resistant (1)
Biologische Heilmittel Heel GmbH (1) · Centers for Disease Control and Prevention (1) · EmeraMed (1) · University of Campinas, Brazil (1) · University of Guadalajara (1)
Brazil (1) · Colombia (1) · Germany (1) · Mexico (1) · South Africa (1)
Andrei C Sposito, MD.PHD (1) · Andres Cadena-Bonfanti, MD (1) · Jussi Saukkonen, MD (1) · Manfred Schedlowski, PhD (1) · Manuel Gonzalez Ortiz, MD MSc Phd (1) · Nesri Padayachin, MBChB (1) · Waffa El-Sadr, MD (1)
PMID 22870441, PMID 23131255, PMID 24515444, PMID 26772822, PMID 30774444, PMID 31073924, PMID 32043983, PMID 32143990, PMID 32346093, PMID 32534337, PMID 32612617, PMID 32678530, PMID 33231615, PMID 33332779, PMID 33649297, PMID 33993853, PMID 34373622, PMID 34632567, PMID 37405785